Study guide
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases
Australian Dental Council ADC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Examination Overview
1.1 ADC Written Examination Structure, Scoring Clusters & Australian Practice Context 1.2 Clinical Scenario Reasoning & Australian Therapeutic Guidelines Alignment
2 Chapter 2: Restorative Dentistry & Fixed Prosthodontics
2.1 Minimal Intervention Dentistry, Caries Risk & Lesion Management 2.2 Direct Restorative Materials, Resin Composites & Dental Amalgam 2.3 Indirect Restorations, Crown Preparation, Veneers & Onlays 2.4 Dental Adhesion, Etch-and-Rinse vs Self-Etch Systems & Hybrid Layer 2.5 Diagnosis & Management of Tooth Wear (Erosion, Attrition, Abrasion, Abfraction)
3 Chapter 3: Dental Pharmacology & Therapeutic Guidelines
3.1 Local Anaesthetic Agents, Vasoconstrictors & Injection Techniques 3.2 Dental Analgesia Protocols, NSAIDs, Paracetamol & Opioid Stewardship 3.3 Dental Antibiotic Prescribing, Prophylaxis & Therapeutic Guidelines 3.4 Management of Patients on Anticoagulants & Antiplatelet Therapy 3.5 Medication-Related Osteonecrosis of the Jaw (MRONJ) Risk & Management
4 Chapter 4: General Medicine & Medically Compromised Patients
4.1 Dental Office Medical Emergencies, Anaphylaxis & Resuscitation Protocols 4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases 4.3 Special Needs Dentistry, Geriatric Care & Dental Management in Pregnancy 4.4 Infective Endocarditis Prophylaxis & Cardiac Risk Assessment
5 Chapter 5: Oral Medicine & Oral Pathology
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases 5.2 Oral Potentially Malignant Disorders (OPMDs) & Oral Cancer Screening 5.3 Salivary Gland Disorders, Sialadenitis & Cysts of the Jaws 5.4 Oral Biopsy Indications, Diagnostic Pathways & Specialist Referral
6 Chapter 6: Endodontics
6.1 Pulpal and Periapical Diagnostic Classification & Diagnostic Testing 6.2 Canal Instrumentation, Working Length & Irrigation Protocols 6.3 Root Canal Obturation, Endodontic Retreatment & Failure Analysis 6.4 Endodontic Management of Traumatic Dental Injuries & Vital Pulp Therapy
7 Chapter 7: Oral Surgery
7.1 Surgical & Simple Exodontia Techniques & Intraoperative Complications 7.2 Assessment & Surgical Management of Impacted Third Molars 7.3 Oroantral Communication, Displacement & Trigeminal Nerve Injury Prevention 7.4 Management of Spreading Odontogenic Infections & Fascial Space Abscesses
8 Chapter 8: Paediatric Dentistry & Orthodontics
8.1 Primary Tooth Pulpotomy, Pulpectomy & Stainless Steel Crown Restoration 8.2 Early Childhood Caries, Space Maintenance & Traumatic Primary Dentition 8.3 Malocclusion Classification, Etiology & Interceptive Orthodontic Management 8.4 Non-Pharmacological Behaviour Guidance, Child Protection & Consent
9 Chapter 9: Periodontics
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment 9.2 Subgingival Debridement, Plaque Control & Antimicrobial Adjuncts 9.3 Periodontal Surgical Flaps, Regenerative Therapy & Furcation Management 9.4 Supportive Periodontal Care, Maintenance Protocols & Risk Re-evaluation
10 Chapter 10: Preventive Dentistry
10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention 10.2 Fluoride Mechanisms, Topical Applications & Community Fluoridation 10.3 Dietary Counselling, Stephan Curve Dynamics & Erosion Prevention 10.4 Pit and Fissure Sealants, Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)
11 Chapter 11: Dental Emergencies
11.1 Emergency Management of Severe Odontogenic Pain & Acute Irreversible Pulpitis 11.2 Acute Management of Avulsed, Luxated & Fractured Permanent Teeth 11.3 Diagnosis, Differentiation & Treatment of Cracked Tooth Syndrome 11.4 Emergency Management of Post-Extraction Hemorrhage & Acute Abscesses
12 Chapter 12: Pain & Behaviour Management
12.1 Assessment & Management of Dental Anxiety, Phobia & Dental Fear 12.2 Nitrous Oxide Inhalation Sedation & Intravenous Sedation Guidelines 12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain 12.4 Informed Consent, Patient Autonomy, Ethics & Professional Boundaries
13 Chapter 13: Removable Prosthodontics
13.1 Complete Denture Design, Impression Techniques & Maxillomandibular Relations 13.2 Removable Partial Denture Design, Surveying, Clasping & RPI System 13.3 Post-Insertion Problems, Sore Spots, Relining & Rebase Procedures 13.4 Denture Stomatitis, Tissue Conditioning & Pre-Prosthetic Surgery
14 Chapter 14: Dental Radiography & Imaging
14.1 Radiation Physics, ALARA Principles, Shielding & Dose Reduction 14.2 Intraoral Radiographic Techniques, Positioning & Geometry 14.3 Radiographic Interpretation, Normal Anatomical Landmarks & Artifacts
15 Chapter 15: Infection Prevention & Control
15.1 Standard & Transmission-Based Precautions in Dental Practice 15.2 Instrument Reprocessing, Autoclaving & Sterilisation Monitoring 15.3 Dental Unit Waterlines, Waste Management & Occupational Exposure Protocols
16 Chapter 16: Dental Implants & Peri-Implant Diseases
16.1 Patient Selection, Bone Density, Anatomic Constraints & Prosthetic Planning 16.2 Peri-Implant Anatomy, Hygiene Protocols & Maintenance Monitoring 16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases
Key Takeaways Explain This Topic AI
Pemphigus vulgaris is a life-threatening autoimmune disorder featuring intraepithelial acantholysis caused by anti-desmoglein 3 IgG autoantibodies, presenting with positive Nikolsky sign and net-like intraepithelial immunofluorescence.
Mucous membrane pemphigoid involves autoantibodies targeting hemidesmosomes (BP180/BP230) leading to subepithelial bullae, desquamative gingivitis, linear basement membrane immunofluorescence, and a risk of scarring ocular lesions requiring urgent ophthalmology referral.
Oral lichen planus is a T-cell-mediated autoimmune condition presenting as reticular, erosive, or bullous lesions; management relies on topical high-potency corticosteroids (e.g., triamcinolone 0.1% in Orabase or betamethasone rinse) per eTG Dentistry.
Recurrent aphthous stomatitis presents on non-keratinized oral mucosa as minor, major, or herpetiform ulcers; systemic underlying causes like iron/B12 deficiency, Coeliac disease, or IBD must be evaluated when ulcers are severe or atypical.
Erythema multiforme is an acute hypersensitivity reaction featuring targetoid cutaneous lesions and severe hemorrhagic crusting of the lips, often triggered by HSV infection (EM minor) or medications (EM major/Stevens-Johnson syndrome).
Last updated: August 2026
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases
Oral mucosal diseases encompass a broad spectrum of ulcerative, vesiculobullous, and immune-mediated disorders. Accurate clinical diagnosis requires a thorough understanding of etiology, clinical presentation, histopathology, direct immunofluorescence (DIF), and evidence-based therapeutic interventions recommended in Therapeutic Guidelines: Dentistry (eTG Dentistry) .
1. Recurrent Aphthous Stomatitis (RAS)
Recurrent Aphthous Stomatitis (RAS) is the most common non-traumatic ulcerative disorder of the oral mucosa, affecting 10–20% of the population. RAS characteristically presents as painful, recurrent, well-demarcated ulcers confined almost exclusively to non-keratinized oral mucosa (e.g., buccal and labial mucosa, ventral tongue, floor of mouth, soft palate).
Clinical Subtypes of RAS
Subtype Frequency Size & Clinical Features Healing Time & Scarring
Minor Aphthae 80–85% Small (<10 mm), round/oval ulcers with a yellowish-grey fibrinopurulent center and prominent erythematous halo. Heals within 7–14 days without scarring.
Major Aphthae ( Sutton Disease ) 10–15% Large (>10 mm), deep, ragged-bordered ulcers often located on soft palate, fauces, or lips. Takes 2 to 6 weeks (or months) to heal; leaves permanent scarring.
Herpetiform Aphthae 5–10% Multiple (10–100) pinhead-sized (1–3 mm) crop-like clusters that coalesce into larger irregular ulcerated areas. Heals within 7–14 days without scarring.
Etiology & Systemic Workup
While idiopathic T-cell-mediated mucosal immune responses drive RAS, candidates in the Australian Dental Council examination must recognize underlying predisposing factors requiring haematological and systemic investigation:
Haematinic Deficiencies: Deficiencies in ferritin (iron), folate, or vitamin B12 occur in up to 20% of RAS patients.
Gastrointestinal & Systemic Diseases: Coeliac disease, Inflammatory Bowel Disease (Crohn's disease, Ulcerative Colitis), Behçet syndrome (triad of oral aphthae, genital ulcers, and uveitis), and HIV infection.
Triggers: Local trauma, stress, sodium lauryl sulfate (SLS) in dentifrices, and systemic drug reactions.
Pharmacological Management (eTG Dentistry)
First-Line Topical Therapy: Topical corticosteroid application to reduce pain and inflammation during the prodromal phase.
Triamcinolone acetonide 0.1% in dental paste (Orabase) applied after meals and at bedtime 2–4 times daily.
Hydrocortisone sodium succinate 2.5 mg buccal tablets allowed to dissolve near the lesion 4 times daily.
Severe / Widespread Recurrences: Betamethasone dipropionate 0.5 mg dissolved in 10 mL water as a 2-minute oral rinse (spit out) 2–4 times daily.
Systemic Therapy: Reserved for refractory major aphthae under specialist Oral Medicine supervision (e.g., short-course systemic prednisolone, colchicine, or thalidomide).
2. Autoimmune Vesiculobullous Diseases
Autoimmune vesiculobullous diseases are caused by autoantibodies directed against cellular adhesion molecules within the epithelium or basement membrane zone. Pemphigus Vulgaris Mucous Membrane Pemphigoid
- ┌─────────────────────────────────┐ ┌─────────────────────────────────┐
- │ Autoantibody vs Desmoglein 3 │ │ Autoantibody vs BP180 / BP230 │
- │ Intraepithelial Acantholysis │ │ Subepithelial Clefting (BMZ) │
- │ Nikolsky Sign: POSITIVE │ │ Nikolsky Sign: VARIABLE / MIN │
- │ DIF: Net-like Intraepithelial │ │ DIF: Linear Basement Membrane │
- └─────────────────────────────────┘ └─────────────────────────────────┘
- A. Pemphigus Vulgaris (PV)
Pemphigus Vulgaris is a life-threatening, intraepithelial autoimmune blistering disorder. In 50–70% of cases, oral lesions precede cutaneous lesions by several months, highlighting the dentist's crucial role in early diagnosis.
Immunopathogenesis: Autoantibodies (IgG) target Desmoglein 3 (and Desmoglein 1), a transmembrane desmosomal cadherin protein, disrupting cell-to-cell adhesion between keratinocytes ( acantholysis ).
Clinical Presentation: Flaccid bullae that rupture rapidly, leaving extensive, painful, irregular erosion surfaces on both keratinized and non-keratinized mucosa. Desquamative gingivitis is common.
Nikolsky Sign: Positive (applying firm lateral pressure to clinically normal-appearing mucosa induces bulla formation or epithelial sloughing).
Histopathology: Intraepithelial / suprabasal clefting . Basal cells remain attached to the basement membrane via hemidesmosomes, creating a characteristic "row of tombstones" appearance. Tzanck cells (acantholytic rounded keratinocytes) are present within the fluid.
Direct Immunofluorescence (DIF): Demonstrates fishnet-like or net-like intraepithelial intercellular deposition of IgG and C3 throughout the spinous layer.
Management: High-dose systemic corticosteroids (prednisolone) combined with steroid-sparing immunosuppressive agents (azathioprine, mycophenolate mofetil, or rituximab) managed collaboratively with an Oral Medicine specialist and dermatologist.
B. Mucous Membrane Pemphigoid (MMP / Cicatricial Pemphigoid)
Mucous Membrane Pemphigoid is a chronic autoimmune subepithelial blistering disease predominantly affecting mucosal sites (oral cavity, conjunctiva, nasopharynx, larynx, esophagus).
Immunopathogenesis: Autoantibodies (IgG, IgA, C3) target structural components of hemidesmosomes and the basement membrane zone (BMZ), including BP180 (collagen XVII) , BP230, and laminin-332 .
Clinical Presentation: Tense, thick-walled bullae that may remain intact for days before rupturing into painful ulcers. Desquamative gingivitis (bright red, glazed, peeling gingiva) is the most frequent oral manifestation.
Ocular Complications: Conjunctival involvement leads to scarring, symblepharon (adhesion of eyelid to eyeball), trichiasis, and irreversible blindness . Any patient diagnosed with MMP MUST be referred urgently to an ophthalmologist.
Histopathology: Subepithelial clefting with total separation of the intact full-thickness epithelium from the underlying lamina propria, accompanied by a dense chronic inflammatory infiltrate.
Direct Immunofluorescence (DIF): Demonstrates a smooth, continuous linear band of IgG and/or C3 deposition along the basement membrane zone .
Management: Topical high-potency corticosteroids (e.g., clobetasol propionate or betamethasone dipropionate) for localized oral disease; systemic immunosuppressants (dapsone, prednisolone, mycophenolate) for widespread or ocular involvement.
3. Oral Lichen Planus (OLP) & Lichenoid Lesions
Oral Lichen Planus (OLP) is a chronic T-cell-mediated inflammatory disease of unknown primary etiology targeting basal keratinocytes.
Clinical Variants of OLP
Reticular OLP: The most common form, characterized by asymptomatic or mildly tender slender, raised, white interlocking lines ( Wickham striae ) surrounded by an erythematous border, typically presenting bilaterally on the posterior buccal mucosa.
Erosive / Atrophic OLP: Painful, erythematous areas of mucosal erosion and ulceration bordered by radiating reticular white striae. Frequently manifests as desquamative gingivitis.
Plaque-like, Papular, & Bullous OLP: Less common forms presenting as fixed white plaques (resembling leukoplakia) or fluid-filled bullae that rupture into erosions.
Oral Lichenoid Lesions (OLL) vs OLP
Oral Lichenoid Contact Lesions: Unilateral lesions occurring in direct anatomical contact with dental restorations (most commonly dental amalgam due to mercury hypersensitivity).
Oral Lichenoid Drug Eruptions: Lesions associated with systemic drug ingestion, including NSAIDs, ACE inhibitors (captopril, enalapril), beta-blockers, thiazide diuretics, and antimalarials.
Histopathology of OLP
Hyperkeratosis (or parakeratosis) with thickening of the granular layer.
Saw-tooth wave-like appearance of rete ridges .
Liquefactive degeneration of the basal cell layer .
Civatte bodies (apoptotic keratinocytes) in the basal and parabasal zones.
Dense, band-like infiltrate of T-lymphocytes restricted to the immediate subepithelial connective tissue zone.
Treatment Protocol (eTG Dentistry)
Asymptomatic reticular OLP requires reassurance and clinical monitoring (at least annual monitoring due to ~1% risk of malignant transformation over 10 years).
Symptomatic erosive/atrophic OLP treatment:
Topical Triamcinolone acetonide 0.1% in Orabase applied 3–4 times daily after meals.
Betamethasone dipropionate 0.5 mg rinse (dissolved in 10 mL water) held in the mouth for 2 minutes 2–4 times daily.
Replacement of amalgam restorations if direct anatomical contact with lichenoid lesion is confirmed.
4. Erythema Multiforme (EM)
Erythema Multiforme is an acute, self-limiting, immune-complex-mediated hypersensitivity reaction.
Etiology:
EM Minor: Triggered in >70% of cases by Herpes Simplex Virus (HSV) reactivation.
EM Major / Stevens-Johnson Syndrome (SJS): Severe form triggered primarily by adverse drug reactions (e.g., sulfonamides, anticonvulsants, NSAIDs, penicillins).
Clinical Presentation: Rapid onset of painful mucosal ulcerations, characteristic hemorrhagic crusting of the lips , and classic cutaneous "target" or "bullseye" concentric ring lesions on hands and extensor surfaces.
Management: Withdrawal of causative drug, systemic antiviral therapy (aciclovir) if HSV-induced, supportive fluid hydration, topical/systemic corticosteroids, and urgent hospital admission for SJS/TEN.